Carregant...
Bispecific T cell engagers for cancer immunotherapy
Bispecific T cell engagers are a new class of immunotherapeutic molecules intended for the treatment of cancer. These molecules, termed BiTEs, enhance the patient’s immune response to tumors by retargeting T cells to tumor cells. BiTEs are constructed of two single chain variable fragments (scFv) co...
Guardat en:
| Publicat a: | Immunol Cell Biol |
|---|---|
| Autors principals: | , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2014
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4445461/ https://ncbi.nlm.nih.gov/pubmed/25367186 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/icb.2014.93 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|